The rapid fermentation and gas production can exacerbate symptoms and cause additional cramping
Indians develop type 2 diabetes at BMI 2325 far below Western thresholds partly due to differences in the incretin system and beta-cell response
6 Adverse effects of GLP1-RA In contrast to the advantages of GLP-1RA the analogues have gastrointestinal side effects distinctly nausea, emesis and reduced appetite with lower risk of hypoglycemia compared to other glucose lowering drugs (110)
As a result, GLP-1(936) reduces the number of granules available for exocytosis in -cells, thereby decreasing the release of glucagon.241 This mechanism decreases intracellular Ca2+ concentration, thereby inhibiting glucagon secretion.241 Additionally, GLP-1(936) can effectively inhibit glucagon secretion induced by -adrenergic stimulation, amino acids, and membrane depolarization, indicating its inhibitory effect under various stimulatory conditions.241 In -cells of patients with T2DM, the ability of GLP-1(936) to inhibit glucagon secretion is lost
Schengen Area : Within the European Schengen zone, crossing internal borders is typically seamless, but carry documentation in case of random checks
This medication works as a glucagon-like peptide-1 (GLP-1) receptor agonist, enhancing the bodys natural response to high blood sugar levels by stimulating insulin secretion
